Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dopamine and Insulin Resistance

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Julia P.Dunn,MD, Vanderbilt University
ClinicalTrials.gov Identifier:
NCT00802204
First received: December 2, 2008
Last updated: December 12, 2015
Last verified: February 2011